107 related articles for article (PubMed ID: 16235530)
21. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
[TBL] [Abstract][Full Text] [Related]
22. NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type.
Liu X; Wang B; Ma X; Guo Y
Jpn J Clin Oncol; 2009 Jul; 39(7):418-24. PubMed ID: 19395464
[TBL] [Abstract][Full Text] [Related]
23. Gastric involvement of extranodal NK/T-cell lymphoma, nasal type: a report of 3 cases with literature review.
Zhang YC; Sha Zhao ; Yu JB; Lei Shi ; He MX; Zhang HY; Liu WP
Int J Surg Pathol; 2008 Oct; 16(4):450-4. PubMed ID: 18492683
[TBL] [Abstract][Full Text] [Related]
24. Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK/T-cell lymphoma.
Nagamine M; Takahara M; Kishibe K; Nagato T; Ishii H; Bandoh N; Ogino T; Harabuchi Y
Virus Genes; 2007 Jan; 34(1):47-54. PubMed ID: 16917737
[TBL] [Abstract][Full Text] [Related]
25. [Amplification and specific expression of T-bet gene in nasal NK/T cell lymphoma].
Ye YH; Li T; Qi WX; Guo ZQ; Zhang B
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(13):881-5. PubMed ID: 16759512
[TBL] [Abstract][Full Text] [Related]
26. AKT plays a role in the survival of the tumor cells of extranodal NK/T-cell lymphoma, nasal type.
Chow C; Liu AY; Chan WS; Lei KI; Chan WY; Lo AW
Haematologica; 2005 Feb; 90(2):274-5. PubMed ID: 15710591
[TBL] [Abstract][Full Text] [Related]
27. [The clinical significance of serum Epstein-Barr virus-determined nuclear antigen 1 (EBNA1)/latent membrane protein 1 (LMP1) assay in patients with nasal type extranodal NK/T-cell lymphoma].
Yao N; Cui X; Wang J
Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):106-10. PubMed ID: 25907839
[TBL] [Abstract][Full Text] [Related]
28. [Expression profile of nasal NK/T cell lymphoma by cDNA microarray].
Wang WH; Li YX; Lin C; Liu XF; Yu ZH; Song YW; Zhang XY; Fu M; Jin J; Wang SL; Liu YP
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):518-22. PubMed ID: 17147117
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type.
Wang B; Li XQ; Ma X; Hong X; Lu H; Guo Y
Am J Hematol; 2008 Oct; 83(10):795-9. PubMed ID: 18756548
[TBL] [Abstract][Full Text] [Related]
31. The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.
Cotta CV; Leventaki V; Atsaves V; Vidaki A; Schlette E; Jones D; Medeiros LJ; Rassidakis GZ
Cancer; 2008 Feb; 112(3):552-61. PubMed ID: 18085637
[TBL] [Abstract][Full Text] [Related]
32. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
[TBL] [Abstract][Full Text] [Related]
33. Extranodal nasal-type natural killer T-cell lymphoma in an adolescent from Bangladesh.
Pol-Rodriguez MM; Fox LP; Sulis ML; Miller IJ; Garzon MC
J Am Acad Dermatol; 2006 May; 54(5 Suppl):S192-7. PubMed ID: 16631938
[TBL] [Abstract][Full Text] [Related]
34. Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas.
Guiretti DM; Chabay PA; Valva P; Stefanoff CG; Barros MH; De Matteo E; Renault IZ; Preciado MV; Hassan R
J Med Virol; 2007 Nov; 79(11):1730-22. PubMed ID: 17854036
[TBL] [Abstract][Full Text] [Related]
35. A simplified tumour model established via Epstein-Barr virus-encoded, nasopharyngeal carcinoma-derived oncogene latent membrane protein 1 in immunocompetent mice.
Chow KP; Wu CC; Chang HY; Chang C; Chang YS
Lab Anim; 2008 Apr; 42(2):193-203. PubMed ID: 18435877
[TBL] [Abstract][Full Text] [Related]
36. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type.
Wu X; Li P; Zhao J; Yang X; Wang F; Yang YQ; Fang F; Xu Y; Zhang H; Wang WY; Yi C
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):619-25. PubMed ID: 18790372
[TBL] [Abstract][Full Text] [Related]
37. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study.
Lee J; Suh C; Park YH; Ko YH; Bang SM; Lee JH; Lee DH; Huh J; Oh SY; Kwon HC; Kim HJ; Lee SI; Kim JH; Park J; Oh SJ; Kim K; Jung C; Park K; Kim WS
J Clin Oncol; 2006 Feb; 24(4):612-8. PubMed ID: 16380410
[TBL] [Abstract][Full Text] [Related]
38. [Establishment of a nude mouse model of orthotopically transplanted human primary malignant lymphoma of the liver].
Liu QZ; Tuo CW; Zhang N; Yang B; Wang MY; Zhu XW
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):244-7. PubMed ID: 16875619
[TBL] [Abstract][Full Text] [Related]
39. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
[TBL] [Abstract][Full Text] [Related]
40. A case of CD30+ nasal natural killer/T-cell lymphoma.
Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
